Lucid Diagnostics Inc.

NASDAQ: LUCD · Real-Time Price · USD
1.02
0.04 (3.96%)
At close: Aug 15, 2025, 2:36 PM

Lucid Diagnostics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.91 -1.12 -0.88 -6.9
PEG Ratio
0.05 0.06 -0.01 -0.03
PS Ratio
9.52 24.25 130.49 387.26
PB Ratio
7.67 -25.48 2.13 3.54
P/FCF Ratio
-0.92 -1.78 -1.61 -10.45
P/OCF Ratio
-0.94 -1.79 -1.66 -10.96
OCF/S Ratio
-10.16 -13.52 -78.74 -35.34
Debt / Equity Ratio
3.94 -6.6 0.09 n/a
Quick Ratio
1.05 0.74 2.88 13.34
Current Ratio
1.07 0.75 2.89 13.45
Asset Turnover
0.14 0.09 0.01 0.01
Interest Coverage
-1.77K -116.54 -7.02K -41.61
Return on Equity
-8.45 22.79 -2.44 -0.51
Return on Assets
-1.48 -1.93 -1.73 -0.48
Return on Invested Capital
-1.73 -3.75 -2.16 -0.5
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-0.9 -2.49 -8.59 -0.17
Net Profit Margin
-10.48 -21.69 -148.99 -56.16
Pretax Profit Margin
-10.48 -21.69 -148.99 -56.16
Operating Profit Margin
-10.6 -19.97 -148.99 -54.84
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-10.2 -20.49 -143.86 -54.83